BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31249419)

  • 1. CRISPR inhibitors.
    Rusk N
    Nat Methods; 2019 Jul; 16(7):577. PubMed ID: 31249419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CRISPR Path to Cutting-Edge Materials.
    Chen M; Luo D
    N Engl J Med; 2020 Jan; 382(1):85-88. PubMed ID: 31893521
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic engineering: Chemical control for CRISPR editing.
    Hilton IB; Gersbach CA
    Nat Chem Biol; 2017 Jan; 13(1):2-3. PubMed ID: 27820804
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 9. CRISPR-Cas in its prime.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
    [No Abstract]   [Full Text] [Related]  

  • 10. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
    Stellos K; Musunuru K
    Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
    [No Abstract]   [Full Text] [Related]  

  • 13. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
    Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
    Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking CRISPR to New Heights.
    Barrangou R
    CRISPR J; 2019 Jun; 2():133. PubMed ID: 31225750
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
    Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
    Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
    Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
    Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.